PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Tilray Brands, Inc. (TLRY.TO)
2.000.05 (2.56%)
1.90 - 2.15
0.48 - 2.54
9.88M / 2.92M (Avg.)
-0.48 | -4.19
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
-2.48%
Negative revenue growth while Healthcare median is 0.00%. Seth Klarman would investigate if the company is losing market share or facing a declining industry.
-18.23%
Negative gross profit growth while Healthcare median is 0.00%. Seth Klarman would suspect poor product pricing or inefficient production.
-61.11%
Negative EBIT growth while Healthcare median is -0.48%. Seth Klarman would check if external or internal factors caused the decline.
-61.11%
Negative operating income growth while Healthcare median is -2.06%. Seth Klarman would check if structural or cyclical issues are at play.
-205.02%
Negative net income growth while Healthcare median is -1.33%. Seth Klarman would investigate factors dragging net income down.
-181.58%
Negative EPS growth while Healthcare median is 0.00%. Seth Klarman would explore whether share dilution or profit declines are to blame.
-181.58%
Negative diluted EPS growth while Healthcare median is 0.00%. Seth Klarman would look for the cause: weakened profitability or heavier share issuance.
9.00%
Share growth above Healthcare median by more than 2x. Jim Chanos would suspect over-dilution or repeated equity raises.
9.00%
Diluted share growth above 2x Healthcare median. Jim Chanos would suspect undue issuance or heavy employee stock compensation.
No Data
No Data available this quarter, please select a different quarter.
-102.79%
Negative OCF growth while Healthcare median is 0.00%. Seth Klarman would ask if accounting or macro issues hamper the firm specifically.
65.09%
FCF growth of 65.09% while Healthcare median is zero. Walter Schloss might see a slight edge that could compound over time.
No Data
No Data available this quarter, please select a different quarter.
998.76%
5Y CAGR of 998.76% while Healthcare is zero. Walter Schloss might see a slight improvement that could compound if momentum builds.
70.17%
3Y CAGR of 70.17% while Healthcare median is zero. Walter Schloss might see a modest improvement overshadowing the broader sector’s stagnation.
99.10%
OCF/share CAGR of 99.10% while Healthcare median is zero. Walter Schloss might see a modest edge that can add up if momentum improves.
-100.92%
Negative 5Y OCF/share CAGR while Healthcare median is 0.00%. Seth Klarman might see a firm-specific issue if peers still expand cash flow.
99.69%
3Y OCF/share growth of 99.69% while Healthcare median is zero. Walter Schloss might see a modest advantage that could compound if momentum holds.
-3992.18%
Negative 10Y net income/share CAGR vs. Healthcare median of 0.00%. Seth Klarman might see a fundamental problem if peers maintain growth.
-2769.45%
Negative 5Y CAGR while Healthcare median is 1.61%. Seth Klarman might see a specific weakness if peers maintain profitable expansions.
-171.89%
Negative 3Y CAGR while Healthcare median is 0.00%. Seth Klarman might see a pressing concern if the rest of the sector is stable or growing.
3001.42%
Equity/share CAGR of 3001.42% while Healthcare median is zero. Walter Schloss might see a modest advantage in net worth accumulation that could matter long term.
191.30%
5Y equity/share CAGR of 191.30% while Healthcare median is zero. Walter Schloss sees a slight positive that might compound if management executes well.
-26.97%
Negative 3Y equity/share growth while Healthcare median is 0.00%. Seth Klarman sees a short-term weakness if peers still expand net worth.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-13.91%
AR shrinking while Healthcare median grows. Seth Klarman sees potential advantage unless it signals declining demand.
-0.89%
Decreasing inventory while Healthcare is rising. Seth Klarman might see an efficiency advantage or possibly a sign of weaker sales future.
1.70%
Asset growth of 1.70% while Healthcare median is zero. Walter Schloss sees a slight advantage if expansions yield good returns on capital.
-24.79%
Negative BV/share change while Healthcare median is -0.06%. Seth Klarman sees a firm-specific weakness if peers accumulate net worth.
72.83%
Debt growth of 72.83% while Healthcare median is zero. Walter Schloss might see a modest difference that matters if interest coverage is tight.
-42.29%
R&D dropping while Healthcare median is rising. Seth Klarman wonders if we risk ceding future innovation or if peers overspend.
39.21%
SG&A growth far above Healthcare median. Jim Chanos sees potential red flags in cost management or diminishing returns on spending.